Thorp Clay

Director at Clearside Biomedical, Inc.; Director, 10% owner at PhaseBio Pharmaceuticals Inc

Sold, on record
$7.8M
Dollars the filings state
Form 4 sales
18
Latest Feb 10, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Oct 5, 2017 2017

    Sold 35,000 shares at $8.57 ($300k)

    Thorp Clay, Director, 10% owner

    Sold 0.9% of holdings ($33.2M position)3.8M shares left1x usual sizeFiling

  2. 2 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Nov 16, 2017 +42 days

    Sold 35,000 shares at $7.00 ($245k)

    Thorp Clay, Director, 10% owner

    Sold 0.9% of holdings ($26.9M position)3.8M shares left1x usual sizeFiling

  3. 3 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Dec 7, 2017 +21 days

    Sold 35,000 shares at $6.22 ($218k)

    Thorp Clay, Director, 10% owner

    Sold 0.9% of holdings ($23.6M position)3.8M shares left1x usual sizeFiling

  4. 4 Form 4 sale Clearside Biomedical, Inc.Unusual
    Mar 23, 2018 +106 days

    Sold 138,861 shares at $12.21 ($1.7M)

    Thorp Clay, Director, 10% owner

    Sold 3.7% of holdings ($46M position)3.6M shares left4x usual sizeFiling

  5. 5 Form 4 sale Clearside Biomedical, Inc.Unusual
    May 18, 2018 +56 days

    Sold 161,139 shares at $13.08 ($2.1M)

    Thorp Clay, Director, 10% owner

    Sold 4.4% of holdings ($47.4M position)3.5M shares left4.6x usual sizeFiling

  6. 6 Form 4 sale PhaseBio Pharmaceuticals IncPlan not stated
    Jun 18, 2019 +396 days

    Sold 400 shares at $14.00 ($6k)

    Thorp Clay, Director, 10% owner

    Sold 0.1% of holdings ($5.8M position)416,418 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale PhaseBio Pharmaceuticals IncPlan not stated
    Jul 1, 2019 +13 days

    Sold 2,908 shares at $14.00 ($41k)

    Thorp Clay, Director, 10% owner

    Sold 0.7% of holdings ($5.9M position)415,959 shares leftFiling

  8. 8 Form 4 sale Clearside Biomedical, Inc.Plan not stated
    Feb 10, 2021 +590 days

    Sold 32,873 shares at $4.43 ($146k)

    Thorp Clay, Director

    Sold 0.9% of holdings ($15.4M position)3.4M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (18)

Form 144 notices and Form 4 sales by Thorp Clay
Source
Feb 10, 2021Feb 12, 2021Clearside Biomedical, Inc.DirectorForm 4 sale32,873$146k0.9%Plan not statedSEC
Jul 1, 2019Jul 3, 2019PhaseBio Pharmaceuticals IncDirector, 10% ownerForm 4 sale2,908$41k0.7%Plan not statedSEC
Jun 18, 2019Jun 20, 2019PhaseBio Pharmaceuticals IncDirector, 10% ownerForm 4 sale400$6k0.1%Plan not statedSEC
May 18, 2018May 21, 2018Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale161,139$2.1M4.4%UnusualSEC
Mar 23, 2018Mar 23, 2018Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale138,861$1.7M3.7%UnusualSEC
Dec 7, 2017Dec 7, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale35,000$218k0.9%Plan not statedSEC
Nov 16, 2017Nov 16, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale35,000$245k0.9%Plan not statedSEC
Oct 5, 2017Oct 5, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale35,000$300k0.9%Plan not statedSEC
Sep 15, 2017Sep 15, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale24,500$184k0.6%Plan not statedSEC
Aug 9, 2017Aug 9, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale24,500$185k0.6%Plan not statedSEC
May 19, 2017May 19, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale24,000$201k0.6%Plan not statedSEC
May 17, 2017May 17, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale44,485$384k1.1%Plan not statedSEC
Apr 19, 2017Apr 19, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale68,485$511k1.7%Plan not statedSEC
Mar 16, 2017Mar 17, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale68,485$450k1.7%Plan not statedSEC
Feb 22, 2017Feb 22, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale27,000$204k0.7%Plan not statedSEC
Feb 17, 2017Feb 17, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale41,485$315k1.0%Plan not statedSEC
Jan 20, 2017Jan 20, 2017Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale68,485$584k1.6%Plan not statedSEC
Jun 7, 2016Jun 7, 2016Clearside Biomedical, Inc.Director, 10% ownerForm 4 sale138$9660.0%Plan not statedSEC